-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DT7nArfNvD6y86CqHevKBriQSpCExdDv5aMJzxcxNIJ0R9WJQSaM9rc1wl9z4jJD LsJvWYgEw6nRw1lVkLlP8w== 0001104659-08-068081.txt : 20081105 0001104659-08-068081.hdr.sgml : 20081105 20081105110244 ACCESSION NUMBER: 0001104659-08-068081 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20081103 FILED AS OF DATE: 20081105 DATE AS OF CHANGE: 20081105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACUSPHERE INC CENTRAL INDEX KEY: 0001115143 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043208947 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 ARSENAL ST CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 6175778800 MAIL ADDRESS: STREET 1: 500 ARSENAL ST CITY: WATERTOWN STATE: MA ZIP: 02472 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CEPHALON INC CENTRAL INDEX KEY: 0000873364 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50405 FILM NUMBER: 081162767 BUSINESS ADDRESS: STREET 1: 41 MOORES ROAD CITY: FRAZER STATE: PA ZIP: 19355 BUSINESS PHONE: 6103440200 MAIL ADDRESS: STREET 1: 41 MOORES ROAD CITY: FRAZER STATE: PA ZIP: 19355 3 1 a3.xml 3 X0203 3 2008-11-03 0 0001115143 ACUSPHERE INC ACUS 0000873364 CEPHALON INC 41 MOORES ROAD FRAZER PA 19355 0 0 1 0 Senior Convertible Note 0.486 2008-11-03 2009-11-03 Common Stock D The note is convertible into common stock under certain circumstances at the option of the Reporting Person for a period of one year. The number of shares of common stock issuable upon conversion of any Conversion Amount (as defined below) shall be the greater of (i) the amount determined by dividing (x) such Conversion Amount by (y) $0.486 and (ii) such number of shares of common stock as shall represent immediately after giving effect to such conversion 51% of the common stock outstanding on a fully diluted basis (excluding options, rights and warrants with exercise prices greater than the greater of (a) three times the average closing price of the Common Stock during the ten trading day period immediately prior to such conversion or (b) $8.00). "Conversion Amount" means the sum of (A) the principal ($15,000,000), (B) accrued and unpaid interest with respect to such principal and (C) accrued and unpaid late charges with respect to such amount being converted. /s/ J. Kevin Buchi 2008-11-05 -----END PRIVACY-ENHANCED MESSAGE-----